London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami 15-04-2024, 19:00

Philips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patients 10-02-2025, 16:00

Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab 16-11-2024, 14:53